Global drug development executives converge on Boston for BioPharm America™ 2016 - Seite 2

"We are thrilled to receive recognition from the Biotech Startup Day pitch competition," said Tweed-Kent. "That such an esteemed panel of biotech investors appreciates our vision is exciting. The Cocoon team is committed to developing new treatments for osteoarthritis that will improve pain and function for millions of patients worldwide."

The winners for the category of "best pitch" were first runner up Jeremy Chrisp, CEO of EpiAxis Therapeutics, and second runner up Christopher Per, CEO of Virvio. For the category of "most investable company, the first runner up was Leo Cytrynbaum, CEO of HepaPharm, and second runner up Jeremy Chrisp, CEO of EpiAxis Therapeutics.

The second one-day program, Digital Medicine Connect, took place on September 15 and focused on challenges and opportunities for digital medicine stakeholders in this emerging field. A highlight of the day was a morning panel moderated by Nicole Fisher or HHR Strategies, with panelists from Evidation Health, Pear Therapeutics and Hogan Lovells speaking directly about findings from the just-published white paper, "The Digital Medicine Crystal Ball: Unlocking the Future of Real-Time, Precise, Effective, Healthcare."

BioPharm America 2017 will be held in Boston September 26–27, 2017.

Additional links and information:

Follow BioPharm America on Twitter: @EBDGroup (hashtag: #BioPharmAmerica).

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group's conferences are run with the support of leading corporations and international trade associations and include:

• BIO-Europe® and BIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
• BioPharm America™, the fastest growing partnering event in North America
• Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
• BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
• ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® Group
• Biolatam®, facilitating partnering among global life sciences executives in Latin America's vibrant life science hubs

EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.

EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.

EBD Group has offices in the USA and Europe.

For more information, please visit www.ebdgroup.com.